http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112998125-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fccd6ae0cf683d929b1cddf15e51c17
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-142
filingDate 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c3064a4a775d95e376c2b355b87877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df88030b4be22d8882fada32649d694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10114d8a3df8974fa597d604a7da1df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a1b668732c60eac2750b7148bbd13f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12676a9439b27a58c2a836e3516e8379
publicationDate 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112998125-A
titleOfInvention Application of avenanthramide compounds and composition thereof
abstract The invention discloses an application of avenanthramide compounds in inhibiting the growth of mucormous roseomonas and preparing a pet bacteriostatic composition. The invention also discloses a pet antibacterial composition which mainly comprises the avenanthramide compound, wherein the avenanthramide compound is composed of an effective dose for inhibiting the mucormycosis, auxiliary materials and physiologically acceptable components for pets. The invention verifies the inhibition effect of the avenanthramide compounds on the mucormophyte through experiments, greatly widens the application field of the avenanthramide compounds, develops the brand-new application of the avenanthramide compounds in pet antibacterial compositions, especially pet antibacterial nutritional pastes, effectively plays the role of inhibiting the infection of the mucormophyte of pets, fills the market blank of inhibiting the mucormophyte of pets, and adds a layer of powerful protection for the guarantee of the health of the pets by combining with the field of pets.
priorityDate 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420129796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426276732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46173706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID827252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925

Total number of triples: 43.